Chargement en cours...
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use
Immune checkpoint inhibition (ICI) is a promising cancer therapy, which has progressed rapidly from a preclinical concept to clinical implementation. Commonly considered targets in ICI are CTLA-4, PD-1/PD-L1, and LAG-3, and the list grows. As ICI is generally only beneficial for a subset of patients...
Enregistré dans:
| Publié dans: | Biomolecules |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843898/ https://ncbi.nlm.nih.gov/pubmed/31569553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100548 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|